Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Nifedipine Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Nifedipine Controlled Release Tablets
  • 1.3.3 Nifedipine Extended Action Tablets
• 1.4 Market Segment by Application
  • 1.4.1 Global Nifedipine Market Share by Application (2019-2025)
  • 1.4.2 Primary Pulmonary Hypertension
  • 1.4.3 Heart Failure
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Nifedipine Market Size
  • 2.1.1 Global Nifedipine Revenue 2014-2025
  • 2.1.2 Global Nifedipine Sales 2014-2025
• 2.2 Nifedipine Growth Rate by Regions
  • 2.2.1 Global Nifedipine Sales by Regions 2014-2019
  • 2.2.2 Global Nifedipine Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Nifedipine Sales by Manufacturers
  • 3.1.1 Nifedipine Sales by Manufacturers 2014-2019
  • 3.1.2 Nifedipine Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Nifedipine Revenue by Manufacturers (2014-2019)
  • 3.2.2 Nifedipine Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Nifedipine Market Concentration Ratio (CR5 and HHI)
• 3.3 Nifedipine Price by Manufacturers
• 3.4 Key Manufacturers Nifedipine Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Nifedipine Market
• 3.6 Key Manufacturers Nifedipine Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Nifedipine Controlled Release Tablets Sales and Revenue (2014-2019)
  • 4.1.2 Nifedipine Extended Action Tablets Sales and Revenue (2014-2019)
• 4.2 Global Nifedipine Sales Market Share by Type
• 4.3 Global Nifedipine Revenue Market Share by Type
• 4.4 Nifedipine Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Nifedipine Sales by Application

6 United States

• 6.1 United States Nifedipine Breakdown Data by Company
• 6.2 United States Nifedipine Breakdown Data by Type
• 6.3 United States Nifedipine Breakdown Data by Application

7 European Union

• 7.1 European Union Nifedipine Breakdown Data by Company
• 7.2 European Union Nifedipine Breakdown Data by Type
• 7.3 European Union Nifedipine Breakdown Data by Application

8 China

• 8.1 China Nifedipine Breakdown Data by Company
• 8.2 China Nifedipine Breakdown Data by Type
• 8.3 China Nifedipine Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Nifedipine Breakdown Data by Company
• 9.2 Rest of World Nifedipine Breakdown Data by Type
• 9.3 Rest of World Nifedipine Breakdown Data by Application
• 9.4 Rest of World Nifedipine Breakdown Data by Countries
  • 9.4.1 Rest of World Nifedipine Sales by Countries
  • 9.4.2 Rest of World Nifedipine Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bayer (Germany)
  • 10.1.1 Bayer (Germany) Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Nifedipine
  • 10.1.4 Nifedipine Product Introduction
  • 10.1.5 Bayer (Germany) Recent Development
• 10.2 Actavis (USA)
  • 10.2.1 Actavis (USA) Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Nifedipine
  • 10.2.4 Nifedipine Product Introduction
  • 10.2.5 Actavis (USA) Recent Development
• 10.3 Teva (Israel)
  • 10.3.1 Teva (Israel) Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Nifedipine
  • 10.3.4 Nifedipine Product Introduction
  • 10.3.5 Teva (Israel) Recent Development
• 10.4 Pfizer (USA)
  • 10.4.1 Pfizer (USA) Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Nifedipine
  • 10.4.4 Nifedipine Product Introduction
  • 10.4.5 Pfizer (USA) Recent Development
• 10.5 Shyndec (China)
  • 10.5.1 Shyndec (China) Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Nifedipine
  • 10.5.4 Nifedipine Product Introduction
  • 10.5.5 Shyndec (China) Recent Development
• 10.6 Honglin (China)
  • 10.6.1 Honglin (China) Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Nifedipine
  • 10.6.4 Nifedipine Product Introduction
  • 10.6.5 Honglin (China) Recent Development
• 10.7 Huanghai (China)
  • 10.7.1 Huanghai (China) Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Nifedipine
  • 10.7.4 Nifedipine Product Introduction
  • 10.7.5 Huanghai (China) Recent Development
• 10.8 Yabao (China)
  • 10.8.1 Yabao (China) Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Nifedipine
  • 10.8.4 Nifedipine Product Introduction
  • 10.8.5 Yabao (China) Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Nifedipine Sales Channels
  • 11.2.2 Nifedipine Distributors
• 11.3 Nifedipine Customers

12 Market Forecast

• 12.1 Global Nifedipine Sales and Revenue Forecast 2019-2025
• 12.2 Global Nifedipine Sales Forecast by Type
• 12.3 Global Nifedipine Sales Forecast by Application
• 12.4 Nifedipine Forecast by Regions
  • 12.4.1 Global Nifedipine Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Nifedipine Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Nifedipine is a drug that belongs to the class of calcium channel blocker, which interrupts the movement of calcium in the walls of the arteries. 
In 2019, the market size of Nifedipine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nifedipine.

This report studies the global market size of Nifedipine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Nifedipine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer (Germany)
Actavis (USA)
Teva (Israel)
Pfizer (USA)
Shyndec (China)
Honglin (China)
Huanghai (China)
Yabao (China)

Market Segment by Product Type
Nifedipine Controlled Release Tablets
Nifedipine Extended Action Tablets

Market Segment by Application
Primary Pulmonary Hypertension
Heart Failure
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Nifedipine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Nifedipine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Nifedipine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025